Amphastar Pharmaceuticals Stock News

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) – Piper Sandler upped their Q4 2021 earnings per share (EPS) estimates for shares of Amphastar Pharmaceuticals in a research note issued on Monday, April

In a report released today, Serge Belanger from Needham maintained a Buy rating on Zogenix (ZGNX), with a price target of $54.00. The company's shares

In a report released today, Serge Belanger from Needham maintained a Buy rating on Zogenix (ZGNX – Research Report), with

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) – Equities research analysts at Piper Sandler cut their Q2 2020 earnings per share estimates for shares of Amphastar Pharmaceuticals in a report released

Most readers would already be aware that Amphastar Pharmaceuticals' (NASDAQ:AMPH) stock increased significantly by 21...

Geode Capital Management LLC boosted its stake in shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the S

Cubist Systematic Strategies LLC reduced its stake in shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 76.4% during the 4th quarter, according to its most recent filing with the Securities and

Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH) today. The company's shares closed last Wednesday at $16.19.

Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals ( AMPH – Research Report ) today. The company’s shares closed last Wednesday at $16.19. According to TipRanks.c

Needham analyst Serge Belanger maintained a Hold rating on Clearside Biomedical (CLSD) today. The company's shares closed last Wednesday at $2.41.

Needham analyst Serge Belanger maintained a Hold rating on Clearside Biomedical (CLSD – Research Report) today. The company’s shares closed

Needham analyst Serge Belanger maintained a Buy rating on Verrica Pharmaceuticals (VRCA) today and set a price target of $20.00. The company's shares

Needham analyst Serge Belanger maintained a Buy rating on Verrica Pharmaceuticals ( VRCA – Research Report ) today and set a price target of $20.00 . The company’s shares closed last Wednesday at

Needham analyst Serge Belanger maintained a Buy rating on Zynerba Pharmaceuticals (ZYNE) today and set a price target of $16.00. The company's shares

Needham analyst Serge Belanger maintained a Buy rating on Zynerba Pharmaceuticals ( ZYNE – Research Report ) today and set a price target of $16.00 . The company’s shares closed last Wednesday at